Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

PTP4A3 Expression Increases Strongly in Lymph Node Metastases from Colorectal Carcinoma

KATARZYNA GUZIŃSKA-USTYMOWICZ, ANNA PRYCZYNICZ and ANDRZEJ KEMONA
Anticancer Research October 2009, 29 (10) 3913-3916;
KATARZYNA GUZIŃSKA-USTYMOWICZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kasia.guzinska@gmail.com
ANNA PRYCZYNICZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDRZEJ KEMONA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Numerous studies have proven that protein tyrosine phosphatase type IV A member 3 (PTP4A3) plays a significant role in local lymph node metastasis from colorectal carcinoma. The aim of the current study was to assess PTP4A3 expression in colorectal carcinomas and lymph nodes in correlation with chosen anatomoclinical parameters. Patients and Methods: Forty-nine patients were analyzed with respect to age, tumor location, pTN stage and local lymph node involvement. The level of PTP4A3 expression was determined immunohistochemically using mouse monoclonal anti- PTP4A3 antibody (monoclonal antibody 3B6, anti-human PTP4A3 from Attogen Biomedical Research, USA). Results: Positive reaction for PTP4A3 in the main tumor mass was observed in 9/49 (18.4%) cases, whereas in metastatic lymph nodes in 22/24 (91.6%) cases. Statistical analysis showed no correlation of PTP4A3 expression in the main tumor mass with such clinical parameters as age, location, histological type or lymph node involvement. Moreover the expression of PTP4A3 in the main tumor mass was not associated with the expression of this protein in lymph node metastases. However, there was a statistically significant correlation between lymph node involvement and PTP4A3 expression in lymph node metastases. Conclusion: The role of the PTP4A3 has not yet been fully elucidated. Our finding indicate PTP4A3 is strongly expressed in colorectal carcinoma metastases of the lymph nodes although the significance of this is unclear.

  • PTP4A3
  • colorectal carcinoma

Colorectal carcinoma is one of the most common causes of death due to malignancy, its incidence showing a growing tendency. Tumor stage is the major prognostic factor and colorectal carcinoma frequently metastasizes to local lymph nodes, liver and lungs. The ability of cancer cells to disseminate from primary tumors to lymph nodes as well as to the nearest and distant tissues and organs is an essential feature of malignant neoplasms and the main cause of therapeutic failures. Formation of metastases is a complex and multistage process involving proteolysis, mobility and migration of cells, proliferation and angiogenesis. Cancer cells released from the primary tumor have to invade the adjacent tissues, permeate lymphatic or blood vessels, migrate through the vascular walls to the adjacent tissues, where they eventually settle, proliferate and induce angiogenesis, forming metastatic foci. Early detection of metastases offers a good chance of a cure. A recent study indicated that the protein formerly known as phosphatase of regenerating liver-3 (PRL-3) newly named protein tyrosine phosphatase type IV A member 3 (PTP4A3) could be a marker for metastasis (1).

The PTP family comprises a large group of enzymes taking part in one of the most important reactions in the cell, i.e. dephosphorylation of tyrosine residues that are involved in activation or inactivation of enzymes. In this way, they regulate a number of cellular processes, both physiological and pathological, including: cell growth, differentiation, cycle or neoplastic transformation. Non-classic representatives of this family include three closely related phosphatases (PTP4A1-PTP4A3) with a unique COOH terminal group. All these proteins have at least 75% of their amino acid sequences in common. PTP4A1 is localized primarily in the brain and muscles, PTP4A2 in skeletal muscles and PTP4A3 in cardiac muscle and skeletal muscles (2). PTP4A3 protein has an active site with the signature motif CX5R, where Cys104 is an enzymatic nucleophile and Arg110 binds to phosphate groups on phosphotyrosine (3). The PTP4A3 molecule contains C-terminal consensus sequence for prenylation, and it is localized in membranes and intracellular structures when prenylated and in the nucleus when it is not. The role of PTP4A3 is not well known. Matter et al. (4) have suggested that PTP4A3 may play a role in the regulation of intracellular calcium transmitters induced by angiotensin II. Wu et al. (5) discovered the presence of PTP4A3 in cellular membrane components in the mitotic phase specifically in metaphase. This location may suggest that PTP4A3 is engaged in cell cycle regulation. The protein also plays a significant role in the induction of angiogenesis by recruiting endothelial cells from the circulating blood and in the formation of microcirculation (6). However, abnormal regulation of tyrosine phosphorylation and dephosphorylation may also lead to neoplastic formation. PTP4A3 protein expression has been detected in cancer of the ovaries (7), breast (8), stomach (9) and large intestine (1).

The aim of the present study was to assess the expression of PTP4A3 in colorectal carcinomas and in lymph nodes in correlation with chosen anatomoclinical parameters.

Patients and Methods

The study was conducted in a group of 49 patients treated surgically due to colorectal carcinoma in the Department of Surgery, the J. Śniadecki Hospital in Bialystok. Sections, 4 μm thick, were cut from paraffin blocks and stained with hematoxylin-eosin (H+E). The routine histopathological assessment was performed for histological type, malignancy grade (G), infiltration depth and the presence of lymph node metastases.

Immunohistochemical analysis. Formalin-fixed and paraffin-embedded tissue specimens were cut on a microtome into 4 μm sections. The sections were deparaffinized in xylene and hydrated in alcohol. To visualize the antigen, the sections were heated in a microwave oven for 15 min in a citrate buffer (pH 6.0). They were incubated with 0.5% hydrogen peroxide solution in methanol in order to block endogenous peroxidase. Incubation was then performed with mouse monoclonal antibody against human PTP4A3 (monoclonal antibody 3B6; Attogen Biomedical Research, USA) over night at 4°C. The secondary reaction was carried out using biotinylated anti-mouse antibody conjugated with horseradish peroxidase (LSAB2, DAKO, Poland). A colour reaction for peroxidase was developed with the chromogen diaminobenzidine (DAKO). Protein expression was determined using a semiquantitative method and assessed as positive (reaction visible in >5% of tumour cells) or negative (lack of reaction, or reaction present in <5% of cells). Reactions were assessed in at least 500 cancer cells in each tissue specimen under a light microscope (×400).

Statistical analysis was conducted using Fisher's test and χ2 analysis. A p-value <0.05 was considered statistically significant.

Results

The study group consisted of 49 patients with colorectal carcinoma pT3G2. Twenty-four patients (49%) had lymph node metastases and four (8%) distant metastases. Cytoplasmic PTP4A3 expression in the main mass of a tumor and no reaction in normal mucosa has been presented in Figure 1. Positive reaction for PTP4A3 protein in the main tumor mass was observed in 9/49 (18.4%) cases, whereas in metastatic lymph nodes, in 22/24 (91.6%) cases. Statistical analysis did not show any correlation between PTP4A3 expression in the main mass of tumor and such clinical parameters as age, location, histological type, the presence of metastases in lymph nodes and distant metastases. The relationship between PTP4A3 expression in the main tumor mass was not correlated with PTP4A3 expression in lymph nodes. Nor was PTP4A3 positivity in lymph nodes correlated with other factors. The relationship between the presence of lymph node involvement and PTP4A3 expression in the lymph nodes was, however, statistically significant (p<0.0001) (Table I).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

PTP4A3 expression in the main tumor mass and in metastatic lymph nodes in association with anatomoclinical parameters.

Discussion

The current study objective was to analyze the role of PTP4A3 expression in colorectal cancer in correlation with the presence of lymph node involvement. The expression of PTP4A3 in the main tumor mass was significantly lower than that in the lymph node metastases. Saha et al. (1), who conducted a molecular study on PTP4A3 gene expression, noticed that it was high in 18/18 metastases, whereas low in non-metastasizing carcinomas and in normal epithelial tissue. Interestingly, in 3/12 metastases they found duplicate copies of the PTP4A3 gene localized in a small amplicon at chromosome 8q24.3, which suggests the significance of the PTP4A3 gene in colorectal carcinoma. In addition, Buffart et al. (10) compared the number of PTP4A3 gene copies in the primary tumor of colorectal carcinoma with and without metastases to the liver. These observations seem to suggest that metastasis may be associated with the genetic profile of the primary tumor and that amplification of the PTP4A3 gene is a mechanism leading to protein over expression. They also found high expression of PTP4A3 in the vascular system of the tumor irrespective of the source of the neoplasm. Bardelli et al. (11) observed high PTP4A3 mRNA expression in colorectal cancer metastases to other organs (in 10/11 metastases to the liver, 6/7 to the lungs, 4/4 to the brain and in 3/3 to the anus), whereas there was no or only low expression of the protein in metastases to these organs from other types of carcinoma (pancreatic, gastric, esophageal) and in non-metastasizing colorectal carcinoma. Moreover, they discovered that the expression of PTP4A3 was higher in over 95% of metastases as compared to the increased number of PTP4A3 gene copies in colorectal cancer (1), thus showing that PTP4A3 gene amplification is not the major cause of the protein overexpression. It was also demonstrated that PTP4A3 overexpression was not due to the presence of neoplastic metastatic cells in the liver. Kato et al. (12) observed similar relations in PTP4A3 protein expression in colorectal carcinomas and their metastases. They also showed that PTP4A3 overexpression is associated with the mobility of neoplastic cells but had no effect on their proliferation.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Immunohistochemical staining. A, Lack of staining for PTP4A3 in normal mucosa. B, Colorectal cancer tissue showing cytoplasmic staining for PTP4A3. Original magnification, ×400.

In an immunohistochemical study concerning PTP4A3 expression, Peng et al. (13) observed high overexpression of this protein in colorectal cancer metastasis to local lymph nodes (53.7% cases) and also in liver metastases (66.7% of cases), whereas there was low protein expression in non-metastasizing tumor (23.9% of cases) as well as in normal colorectal epithelium (7.1% of cases). The expression of PTP4A3 protein in the main tumor was found to correlate with lymph node involvement, but not with the presence of distant metastases. In our study, the expression of PTP4A3 in lymph node metastases was high in 22/24 cases, but the protein expression in the main tumor mass did not correlate with the presence of metastases, in contrast to the finding of Wang et al. (14).

Although our findings show no correlation between PTP4A3 expression and colorectal cancer metastasis per se, its high expression in lymph node metastases is of significance. PTP4A3 involvement in colorectal cancer metastasis needs to be further investigated.

Acknowledgements

We thank Dr. Jerzy Hapanowicz, Department of Surgery Hospital in Bialystok for cooperation.

  • Received May 11, 2009.
  • Revision received August 30, 2009.
  • Accepted September 1, 2009.
  • Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Saha S,
    2. Bardelli A,
    3. Buckhaults P,
    4. Velculescu VE,
    5. Rago C,
    6. St Croix B,
    7. Romans KE,
    8. Choti MA,
    9. Lengauer C,
    10. Kinzler KW,
    11. Vogelstein B
    : A phosphatase associated with metastasis of colorectal cancer. Science 294: 1343-1346, 2001.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Bessette DC,
    2. Qiu D,
    3. Pallen CJ
    : PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev 27: 231-252, 2008.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Kim KA,
    2. Song JS,
    3. Jee J,
    4. Sheen MR,
    5. Lee C,
    6. Lee TG,
    7. Ro S,
    8. Cho JM,
    9. Lee W,
    10. Yamazaki T,
    11. Jeon YH,
    12. Cheong C
    : Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett 565: 181-187, 2004.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Matter WF,
    2. Estridge T,
    3. Zhang C,
    4. Belagaje R,
    5. Stancato L,
    6. Dixon J,
    7. Johnson B,
    8. Bloem L,
    9. Pickard T,
    10. Donaghue M,
    11. Acton S,
    12. Jeyaseelan R,
    13. Kadambi V,
    14. Vlahos CJ
    : Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem Biophys Res Commun 283: 1061-1068, 2001.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Wu X,
    2. Zeng H,
    3. Zhang X,
    4. Zhao Y,
    5. Sha H,
    6. Ge X,
    7. Zhang M,
    8. Gao X,
    9. Xu Q
    : Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164: 2039-2054, 2004.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Guo K,
    2. Li J,
    3. Wang H,
    4. Osato M,
    5. Tang JP,
    6. Quah SY,
    7. Gan BQ,
    8. Zeng Q
    : PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Cancer Res 66: 9625-9635, 2006.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Polato F,
    2. Codegoni A,
    3. Fruscio R,
    4. Perego P,
    5. Mangioni C,
    6. Saha S,
    7. Bardelli A,
    8. Broggini M
    : PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res 11: 6835-6839, 2005.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Wang L,
    2. Peng L,
    3. Dong B,
    4. Kong L,
    5. Meng L,
    6. Yan L,
    7. Xie Y,
    8. Shou C
    : Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol 17: 1517-1522, 2006.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Miskad UA,
    2. Semba S,
    3. Kato H,
    4. Yokozaki H
    : Expression of PRL-3 phosphatase in human gastric carcinoma: close correlation with invasion and metastasis. Pathobiology 71: 176-184, 2004.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Buffart TE,
    2. Coffa J,
    3. Hermsen MA,
    4. Carvalho B,
    5. van der Sijp JR,
    6. Ylstra B,
    7. Pals G,
    8. Schouten JP,
    9. Meijer GA
    : DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cell Oncol 27: 57-65, 2005.
    OpenUrlPubMed
  11. ↵
    1. Bardelli A,
    2. Saha S,
    3. Sager JA,
    4. Romans KE,
    5. Xin B,
    6. Markowitz SD,
    7. Lengauer C,
    8. Velculescu VE,
    9. Kinzler KW,
    10. Vogelstein B
    : PRL-3 expression in metastatic cancers. Clin Cancer Res 9: 5607-5615, 2003.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Kato H,
    2. Semba S,
    3. Miskad UA,
    4. Seo Y,
    5. Kasuga M,
    6. Yokozaki H
    : High expression of PRL-3 promotes cancer cell motility and liver metastasis in huma colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 10: 7318-7328, 2004.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Peng L,
    2. Ning J,
    3. Meng L,
    4. Shou C
    : The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J Cancer Res Clin Oncol 130: 521-526, 2004.
    OpenUrlPubMed
  14. ↵
    1. Wang Y,
    2. Li ZF,
    3. He J,
    4. Li YL,
    5. Zhu GB,
    6. Zhang LH,
    7. Li YL
    : Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int J Colorectal Dis 22: 1179-1184, 2007.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 29 (10)
Anticancer Research
Vol. 29, Issue 10
October 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PTP4A3 Expression Increases Strongly in Lymph Node Metastases from Colorectal Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
PTP4A3 Expression Increases Strongly in Lymph Node Metastases from Colorectal Carcinoma
KATARZYNA GUZIŃSKA-USTYMOWICZ, ANNA PRYCZYNICZ, ANDRZEJ KEMONA
Anticancer Research Oct 2009, 29 (10) 3913-3916;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
PTP4A3 Expression Increases Strongly in Lymph Node Metastases from Colorectal Carcinoma
KATARZYNA GUZIŃSKA-USTYMOWICZ, ANNA PRYCZYNICZ, ANDRZEJ KEMONA
Anticancer Research Oct 2009, 29 (10) 3913-3916;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • TIG1 Inhibits the mTOR Signaling Pathway in Malignant Melanoma Through the VAC14 Protein
  • Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells
  • Differential Effects of Anti-PD-1/PD-L1 Checkpoint Inhibitors on Adhesion Molecules and Cytokine Secretion by THP-1 Monocytes
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire